PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
HEAL vs. IHE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

HEAL vs. IHE

Last updated Jun 4, 2026

HEAL (Global X HealthTech ETF) and IHE (iShares U.S. Pharmaceuticals ETF) are both Health & Biotech Equities funds - HEAL tracks the Global X HealthTech Index while IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index. Both are passively managed. Over the past 5 years, HEAL returned -14.71%/yr vs 9.98%/yr for IHE. At a 0.47 correlation, their price movements are largely independent. HEAL charges 0.50%/yr vs 0.42%/yr for IHE.

Performance

HEAL vs. IHE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Global X HealthTech ETF (HEAL) and iShares U.S. Pharmaceuticals ETF (IHE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HEAL achieves a -15.57% return, which is significantly lower than IHE's 6.47% return.

HEAL

1D
-1.16%
1M
-2.59%
YTD
-15.57%
6M
-20.78%
1Y
-22.08%
3Y*
-10.46%
5Y*
-14.71%
10Y*
—

IHE

1D
1.16%
1M
1.80%
YTD
6.47%
6M
8.51%
1Y
40.15%
3Y*
17.47%
5Y*
9.98%
10Y*
7.81%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HEAL vs. IHE - Yearly Performance Comparison

2026 (YTD)202520242023202220212020
HEAL
Global X HealthTech ETF		-15.57%-0.62%-2.87%-12.61%-29.99%-14.21%23.87%
IHE
iShares U.S. Pharmaceuticals ETF		6.47%31.69%8.13%1.06%-4.87%13.07%13.86%

Correlation

The correlation between HEAL and IHE is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.37

Correlation (3Y)
Calculated over the trailing 3-year period

0.39

Correlation (5Y)
Calculated over the trailing 5-year period

0.46

Correlation (All Time)
Calculated using the full available price history since Jul 31, 2020

0.47

The correlation between HEAL and IHE shifts across timeframes, from 0.37 (1 year) to 0.47 (all time), reflecting how their relationship changes across market environments.

HEAL vs. IHE - Sectors Allocation Comparison

Sectors
HEAL
IHE

Healthcare

96.0%
100.0%

Technology

3.2%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Utilities

-

-

Healthcare

HEAL
96.0%
IHE
100.0%

Technology

HEAL
3.2%
IHE

-

Basic Materials

HEAL

-

IHE

-

Communication Services

HEAL

-

IHE

-

Consumer Cyclical

HEAL

-

IHE

-

Consumer Defensive

HEAL

-

IHE

-

Energy

HEAL

-

IHE

-

Financial Services

HEAL

-

IHE

-

Industrials

HEAL

-

IHE

-

Real Estate

HEAL

-

IHE

-

Utilities

HEAL

-

IHE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Global X HealthTech ETF

iShares U.S. Pharmaceuticals ETF

Often compared with HEAL:
HEAL vs. HTECHEAL vs. ARKGHEAL vs. AIQHEAL vs. DFENHEAL vs. IUHC.LHEAL vs. IBBHEAL vs. IDNA
Often compared with IHE:
IHE vs. PPHIHE vs. XPHIHE vs. XLVIHE vs. VYMIHE vs. PJPIHE vs. IAKIHE vs. BBP

Return for Risk

HEAL vs. IHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
HEAL
HEAL Risk / Return Rank: 22
Overall Rank
HEAL Sharpe Ratio Rank: 11
Sharpe Ratio Rank
HEAL Sortino Ratio Rank: 22
Sortino Ratio Rank
HEAL Omega Ratio Rank: 22
Omega Ratio Rank
HEAL Calmar Ratio Rank: 33
Calmar Ratio Rank
HEAL Martin Ratio Rank: 11
Martin Ratio Rank
IHE
IHE Risk / Return Rank: 7474
Overall Rank
IHE Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 7575
Sortino Ratio Rank
IHE Omega Ratio Rank: 6565
Omega Ratio Rank
IHE Calmar Ratio Rank: 8585
Calmar Ratio Rank
IHE Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HEAL vs. IHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X HealthTech ETF (HEAL) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

HEALIHEDifference
Sharpe ratioReturn per unit of total volatility
-1.01
2.36

-3.38

Sortino ratioReturn per unit of downside risk
-1.40
3.43

-4.83

Omega ratioGain probability vs. loss probability

0.85

1.40

-0.55

Calmar ratioReturn relative to maximum drawdown

-0.72

4.76

-5.48

Martin ratioReturn relative to average drawdown

-1.46

14.35

-15.81

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HEAL vs. IHE - Sharpe Ratio Comparison

The current HEAL Sharpe Ratio is -1.01, which is lower than the IHE Sharpe Ratio of 2.36. The chart below compares the historical Sharpe Ratios of HEAL and IHE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

HEALIHEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.01

2.36

-3.38

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.56

0.62

-1.18

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

—

0.43

—

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.39

0.51

-0.90

Drawdowns

HEAL vs. IHE - Drawdown Comparison

The maximum HEAL drawdown since its inception was -65.76%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for HEAL and IHE.

Loading charts...

Drawdown Indicators

HEALIHEDifference

Max Drawdown

Largest peak-to-trough decline

-65.76%

-38.20%

-27.56%

Max Drawdown (1Y)

Largest decline over 1 year

-30.71%

-8.47%

-22.24%

Max Drawdown (3Y)

Largest decline over 3 years

-35.78%

-15.92%

-19.86%

Max Drawdown (5Y)

Largest decline over 5 years

-60.36%

-16.03%

-44.33%

Max Drawdown (10Y)

Largest decline over 10 years

—

-29.59%

—

Current Drawdown

Current decline from peak

-63.55%

-2.80%

-60.75%

Average Drawdown

Average peak-to-trough decline

-43.02%

-7.92%

-35.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.13%

2.81%

+12.32%

Volatility

HEAL vs. IHE - Volatility Comparison

The current volatility for Global X HealthTech ETF (HEAL) is 5.21%, while iShares U.S. Pharmaceuticals ETF (IHE) has a volatility of 5.53%. This indicates that HEAL experiences smaller price fluctuations and is considered to be less risky than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

HEALIHEDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.21%

5.53%

-0.32%

Volatility (6M)

Calculated over the trailing 6-month period

15.69%

12.48%

+3.21%

Volatility (1Y)

Calculated over the trailing 1-year period

21.89%

17.07%

+4.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.37%

16.24%

+10.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.18%

18.05%

+8.13%

HEAL vs. IHE - Expense Ratio Comparison

HEAL has a 0.50% expense ratio, which is higher than IHE's 0.42% expense ratio.

Dividends

HEAL vs. IHE - Dividend Comparison

HEAL's dividend yield for the trailing twelve months is around 0.39%, less than IHE's 1.65% yield.

PositionTTM20252024202320222021202020192018201720162015
HEAL
Global X HealthTech ETF		0.39%0.33%0.00%0.00%0.00%0.00%0.03%0.00%0.00%0.00%0.00%0.00%
IHE
iShares U.S. Pharmaceuticals ETF		1.65%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%

Frequently Asked Questions

HEAL and IHE have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IHE has higher volatility (5.53%) compared to HEAL (5.21%). In terms of maximum drawdown, HEAL dropped -65.76% vs IHE's -38.20%.

On 5-year performance, IHE leads with 9.98% vs -14.71% for HEAL. On fees, IHE is cheaper at 0.42% per year. On volatility, HEAL has been the lower-risk option at 5.21%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, IHE has performed better with a 9.98% return vs -14.71%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IHE is cheaper with a 0.42% expense ratio, compared with 0.50% for HEAL.

IHE has the higher dividend yield at 1.65%, compared with 0.39% for HEAL.

HEAL tracks Global X HealthTech Index, while IHE tracks Dow Jones U.S. Select Pharmaceuticals Index. They also come from different issuers: Global X and iShares. Their fees differ too: 0.50% for HEAL and 0.42% for IHE.

IHE currently has the higher Sharpe Ratio (2.36 vs -1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HEAL and IHE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer